The United States Drug Enforcement Administration (DEA) has initiated a significant regulatory crackdown on a burgeoning class of synthetic alkaloids…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
The United States Drug Enforcement Administration (DEA) has officially moved to curtail the proliferation of highly potent, synthetic derivatives associated…
Read More
DEA targets synthetic kratom-related products mitragynine pseudoindoxyl, MGM-15, and MGM-16 for temporary controls in Schedule I
In a significant move to address the rising proliferation of potent, lab-engineered substances, the U.S. Drug Enforcement Administration (DEA) has…
Read More
Clinical Laboratories Bolster National Disease Surveillance Amidst Temporary CDC Testing Halt
A temporary cessation of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has ignited a…
Read MoreYOU MAY HAVE MISSED
